CMN-005 by CoImmune for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.

Opinion | Why Measles Is ‘Coming in Hot’ in 2024

Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is

August 14, 2024

Digital Dilemma: How Social Media Impacts Youth Mental Health

Lindsay Oberleitner, PhD, Education Director at SimplePractice In the current digital landscape, the impact of social media on youth mental health is becoming an increasingly pressing concern. Dr. Vivek

October 3, 2023

Vitamin D receptor presence in breast cancer tumors linked to better survival outcomes

Research identifies vitamin D receptors (VDR) in breast cancer tumors as a promising prognostic marker, linking VDR presence to tumor characteristics, survival outcomes, and potentially

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.